Johnson & Johnson (BCBA:JNJ)

Market Cap	713.58T
Revenue (ttm)	122.42T
Net Income (ttm)	33.37T
Shares Out	n/a
EPS (ttm)	13,747.19
PE Ratio	21.38
Forward PE	18.44
Dividend	320.90 (1.58%)
Ex-Dividend Date	Nov 25, 2025

Volume	6,127
Average Volume	13,326
Open	20,800
Previous Close	20,150
Day's Range	20,000 - 20,800
52-Week Range	10,425 - 21,700
Beta	0.36
RSI	59.15
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD